News

Neurochem’s independent safety review board (ISRB) for Alzhemed is made up of independent medical experts who monitor and evaluate the safety of patients taking part in the Alzhemed

The clinical trial, called PACCE, is a randomized, multi-center, open-label study, with endpoints of progression-free survival, overall survival and response rate. Enrollment of approximately 1,000 patients is already

A bioequivalence study is required to demonstrate that a co-formulated product results in the same levels of medication in the blood as achieved when the individual products are

GPC Biotech, a public company, is primarily focused on the research and development of cancer drugs. Ingenium is a private company focused on the treatment of pain. The

Heat shock protein 27 (Hsp27) is a small protein that is over-expressed in numerous tumor types and is associated with treatment resistance through its ability to help cancer

Sandoz is being relocated as Novartis works on plans to merge its generics unit with recently acquired companies Hexal AG and Eon Labs. While Hexal is already based

The study found that people who carried certain genotypes responded less favorably to rosiglitazone, a drug often prescribed for people with diabetes, than carriers of other genotypes. Rosiglitazone

The two companies have entered into a collaboration agreement for Glenmark’s PDE4 inhibitor GRC 3886, which is currently in development for chronic obstructive pulmonary disorder (COPD) and asthma.

Avanafil is Vivus’ investigational oral phosphodiesterase type 5 (PDE5) inhibitor being developed for the treatment of erectile dysfunction. Nitrates, such as glyceryl trinitrate (GTN), are commonly used to